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The study of DNA sequence variation has been transformed by recent advances in DNA sequencing technol-
ogies. Determination of the functional consequences of sequence variant alleles offers potential insight as to
how genotype may inﬂuence phenotype. Even within protein coding regions of the genome, establishing the
consequences of variation on gene and protein function is challenging and requires substantial laboratory inves-
tigation. However, a series of bioinformatics tools have been developed to predict whether non-synonymous
variants are neutral or disease-causing. In this study we evaluate the performance of nine such methods (SIFT,
PolyPhen2, SNPs&GO, PhD-SNP, PANTHER, Mutation Assessor, MutPred, Condel and CAROL) and developed
CoVEC (Consensus Variant Effect Classiﬁcation), a tool that integrates the prediction results from four of these
methods. We demonstrate that the CoVEC approach outperforms most individual methods and highlights the
beneﬁt of combining results from multiple tools.
© 2013 The Authors. Published by Elsevier Inc.
1. Introduction
DNA sequencing has entered a new era, in which high throughput
technologies enable large amounts of sequence data to be generated
quickly and at low cost. Much of the data generated is aimed at the
discovery of disease causing genetic variation. A key challenge in
this process is the interpretation of the functional consequences of
variant alleles. Given the extensive number of variants identiﬁed by
whole genome or exome re-sequencing studies, it is infeasible to in-
terrogate the functional consequences of all variant alleles at all
gene loci experimentally.
A number of bioinformatics solutions for the annotation, scoring
and classiﬁcation of variants have been developed to address
this challenge [1–27] and several comprehensive overviews of the
available tools and methods have been carried out [28–31]. Such
tools are providing a supportive role in the experimental validation
of disease-related alleles, by prioritizing candidate variants with pre-
dicted functional consequences as causes of speciﬁc inherited
diseases and cancers. These bioinformatics approaches draw from a
broad range of existing knowledge about the structure, function and
conservation of genes, transcripts and proteins in which the variants
are located.
In this article, our aim is to identify the best method with which to
prioritize non-synonymous substitutions as candidate causes of
monogenic diseases. We assess the performance of eight existing
tools that draw on different resources to classify non-synonymous
single nucleotide substitutions as likely or unlikely to have a serious
impact on a protein's function. We also propose our own consensus
strategy. The tools evaluated here are SIFT [1], PolyPhen2 [2],
MutPred [3], SNPs&GO [4], PANTHER [5], PhD-SNP [6] and Mutation
Assessor [7], as well as the consensus classiﬁers Condel [17] and
CAROL [9].
SIFT, PANTHER and Mutation Assessor base their predictions on se-
quence conservation only, using multiple sequence alignments they
each build independently, whereas PolyPhen2, SNPs&GO, MutPred
and PhD-SNP combine homology information with various types of
structural and functional annotation of the proteins, such as amino
acid properties, the location of functional sites, and the secondary struc-
ture andmembrane topology of the protein. MutPred additionally eval-
uates the effect of the variant to protein stability based on just the
amino acid sequence, while PolyPhen2 can optionally use information
from an available homologous protein 3D structure to assess the effect
to protein stability. An alternative version of SNPs&GO also integrates
information from 3D structures [12]. Aside from the ﬁnal classiﬁcation
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of the variant, PolyPhen2, MutPred and Mutation Assessor offer addi-
tional information on what the actual biological effect of the variant
may be. As far as the consensus approaches are concerned, CAROL com-
bines the prediction scores of SIFT and PolyPhen2, while Condel addi-
tionally uses the score from Mutation Assessor.
SIFT, PANTHER, PolyPhen2, Mutation Assessor and Condel employ
explicit rules or mathematical models in order to reach their verdict
and are, thus, not biased by the selection of a training dataset of mu-
tations. On the contrary, PhD-SNP and SNPs&GO use support vector
machine (SVM) classiﬁers trained on variants extracted from Uniprot
[32], whereas MutPred uses a Random Forest (RF) classiﬁer trained
on disease variants from HGMD [33] and neutral variants from
Uniprot. CAROL's classiﬁcation threshold has been calibrated using
disease variants from HGMD and neutral variants from the 1000 Ge-
nomes Project [34].
All of these tools require minimal prior information from the user
and, with the exception of PhD-SNP and SNPs&GO, are able to process
batch queries directly through their available interfaces. All seven
stand-alone methods accept amino acid substitutions as queries,
whilst PolyPhen2 and SIFT also accept nucleotide substitution
queries. Both consensus methods accept pre-obtained scores as
input, although Condel's website can also mediate query submission
to the three tools it combines.
Together, these tools encompass a broad range of non-synonymous
DNA sequence variant classiﬁcation criteria and methods. They have
each been independently evaluated previously [17,31], but never to-
gether on a common dataset. In this studywe propose a consensus clas-
siﬁer based on these tools, and demonstrate improvements in accuracy.
2. Results
2.1. Evaluation of the selected tools
We submitted our positive and negative data sets (see Materials
and methods), representing a total of 15570 variants to the seven se-
lected individual classiﬁcation tools and evaluated their classiﬁcation
performance. We measured the prediction rate, the sensitivity and
speciﬁcity, the overall correct rate, the Matthews correlation coefﬁ-
cient and the area under the ROC curve. As these performance metrics
only apply to binary classiﬁcations, different scenarios were consid-
ered (see Methods). Table 1 presents the most favorable of the sce-
narios, whereas the full results are available in Additional ﬁle 1.
The prediction rate for all methods apart from PANTHER is N0.9.
SNPs&GO, PhD-SNP and MutPred report predictions for nearly all of
the variants submitted. When the intermediate class is considered
as damaging, MutPred is the most sensitive of all of the tested
classiﬁers (0.94) and also has the highest overall correct rate (0.92).
However, SNPs&GO demonstrated the highest speciﬁcity (0.95).
PolyPhen2 was executed several times, using different parameters
and producing notably different results. PolyPhen2 provides two clas-
siﬁers trained on different datasets [2]: The HumVar set consists of
the disease-causing mutations annotated in Uniprot as positive
cases, and variants without annotated implication in disease as nega-
tive cases. The HumDiv is a smaller and stricter set, consisting only of
variants implicated in monogenic (Mendelian) diseases in the
Uniprot annotation as positive cases, and of observed differences be-
tween human proteins and their closely related mammalian equiva-
lents as negative cases. Both displayed the same prediction rate,
correct ratio and correlation. However, the HumVar classiﬁer proved
to be more sensitive, whereas the HumDiv one was more selective.
When the corresponding amino acid sequence was explicitly provid-
ed to PolyPhen2, the prediction rate increased.
Evaluating the area under the ROC curves (Table 1) demonstrates
that MutPred has the highest classiﬁcation power, followed by
SNPs&GO. PhD-SNP does not output any score values, therefore it
was not possible to evaluate its performance using this method. The
actual ROC curves are available in Additional ﬁle 2.
2.2. Evaluation of consensus strategies
Our independent evaluation of these seven prediction tools dem-
onstrates how each of the different approaches has different attri-
butes. We therefore evaluated methods of combining the outputs
from these tools in order to improve the predictive performance. Pre-
viously, Gonzalez-Perez and Lopez-Bigas [17] developed Condel,
which combines the output from PolyPhen2, SIFT and Mutation As-
sessor. Our evaluation of this approach demonstrates that in compar-
ison to the three methods it combines, it performed better than SIFT
and comparably to Mutation Assessor. It also showed a better correct
rate and correlation than PolyPhen2, but the latter retained consider-
ably higher sensitivity. Another consensus tool, CAROL [9], which
combines SIFT and PolyPhen2, showed similar performance to
Condel.
For the development of our own consensus approach, we evaluat-
ed combinations of different subgroups of the six individual classiﬁers
(MutPred was excluded because of the direct overlap of our test data
with the data used in the development of this tool; see Discussion)
using a weighted majority vote score (WMV) and a support vector
machine (SVM) approach (Table 2). Using theWMV, the highest accu-
racy in prediction was obtained from the combination of PolyPhen2
(HumDiv), SNPs&GO and Mutation Assessor, which produced both
higher correlation and a higher correct rate than any of the individual
methods involved. Its speciﬁcity was high and comparable to that of
Table 1
Evaluation results for the individual tools. Prediction rate, sensitivity, speciﬁcity, correct rate, Matthews correlation coefﬁcient and area under the ROC curve, for SIFT, PolyPhen2,
MutPred, SNPs&GO, PANTHER, PhD-SNP and Mutation Assessor, [a] treating low conﬁdence predictions as damaging, and [b] treating them as neutral. PhD-SNP does not output its
classiﬁcation score, thus it was not possible to plot a ROC curve for this tool. PolyPhen2 was executed with various parameters: Two classiﬁers are offered, trained on different
datasets (HumDiv and HumVar [2]). Additionally, we supplied the amino acid substitution (aa) instead of the nucleotide change, and also explicitly supplied the amino acid se-
quence (seq).
Tool Pred.
Rate
Sensitivity Speciﬁcity Correct Rate MCC AUC
[a] [b] [a] [b] [a] [b] [a] [b]
SIFT 0.93 0.73 0.64 0.86 0.88 0.79 0.75 0.59 0.55 0.87
PolyPhen2
(HumDiv) 0.92 0.84 0.71 0.77 0.87 0.80 0.74 0.61 0.61 0.88
(HumVar) 0.92 0.76 0.61 0.86 0.94 0.81 0.73 0.62 0.59 0.90
(Humdiv, aa) 0.91 0.84 0.71 0.76 0.87 0.80 0.74 0.60 0.62 0.88
(HumDiv, aa + seq) 0.96 0.84 0.71 0.76 0.87 0.80 0.74 0.60 0.62 0.88
MutPred 1.00 0.94 0.56 0.90 0.95 0.92 0.73 0.84 0.56 0.97
SNPs&GO 1.00 0.71 0.71 0.95 0.95 0.83 0.83 0.68 0.68 0.93
PANTHER 0.68 0.69 0.69 0.84 0.84 0.75 0.75 0.52 0.52 0.84
PhD-SNP 1.00 0.62 0.62 0.78 0.78 0.70 0.70 0.41 0.41 –
Mut. Assessor 0.90 0.76 0.34 0.85 0.98 0.81 0.57 0.62 0.04 0.89
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the most speciﬁc method involved (SNPs&GO), and its sensitivity was
higher than two of the constituent methods, SNPs&GO and Mutation
Assessor, but not as high as PolyPhen2. Interestingly, the application
of the WMV to the combination of SIFT, PolyPhen2 and Mutation As-
sessor, which is the combination employed by Condel, was not the
highest performing combination. Its performance was, however, al-
most identical to Condel's. Similar observations are made for the com-
bination of SIFT and PolyPhen2, which are the tools employed by
CAROL.
The SVM classiﬁcation approach using scores generated by SIFT,
PolyPhen2, SNPs&GO and Mutation Assessor provided elevated accu-
racy and correlation in comparison to our most accurateWMV combi-
nation and also in comparison to Condel and CAROL. The use of the
linear and RBF kernels produced almost identical predictions. The
speciﬁcity of the SVM classiﬁers was marginally lower than the best
performing WMV classiﬁer but sensitivity was improved. In compari-
son to the individual constituent tools the SVM approachmatched the
highest observed sensitivity of the individual tools (PolyPhen2) and
provided equivalent or improved correct rate and correlation com-
pared to the respective highest values obtained by individual tools.
It also provides the second highest observed speciﬁcity out of all the
tools discussed in this article.
2.3. Additional validation
As experimentally validated variants are relatively few, there is a high
risk of datasets overlapping the training sets of methods and causing
biases, especially with regards to disease-causing variants. Therefore,
we collected an additional separate set of 4985 disease-associated vari-
ants (see Materials and methods) and submitted them for individual
and consensus classiﬁcation. The results are shown in Table 3.
The highest sensitivity is demonstrated by MutPred, followed by
our own CoVEC. By comparison to the sensitivities measured on the
HGMD-derived dataset (Tables 1 and 2), most of the individual
tools displayed a similar respective sensitivity. However, SNPs&GO
and PhD-SNP increased noticeably in sensitivity, as did all the consen-
sus tools.
3. Discussion
The results summarized in Table 1 show that, in comparison to all
the other tools, PANTHER produced a signiﬁcantly lower prediction
rate (0.68 compared to N0.9). This may result from some substitu-
tions not falling in positions covered by the multiple sequence align-
ments in its library [5]. Indeed, the authors of SNPs&GO, through
which we obtained our PANTHER predictions, reported a similarly
low prediction rate (0.76) when benchmarking PANTHER [4].
Also notable is the observation that, PolyPhen2's prediction rate
improved when the amino acid sequence was explicitly provided.
This likely highlights shortcomings in the automated retrieval of an-
notation from diverse resources. Specifying the sequence takes this
task away from the tool and reduces the chance of mismatch between
the variant and the protein. SNPs&GO and Mutation Assessor also ac-
commodate the explicit speciﬁcation of the amino acid sequence to
be used, whereas the other tools retrieve the sequence automatically,
based on the supplied identiﬁer code or genomic coordinates.
Also of interest, is the comparison between Condel, CAROL and our
WMV combination of the same tools employed by Condel and CAROL
respectively (Table 2). Condel utilizes a sophisticated weighting sys-
tem, based on the probability that a prediction by a method is a
false positive or false negative, pre-calculated on a speciﬁed reference
data set (HumVar by default) [17]. This weighting was designed to
favor conﬁdent classiﬁcations by penalizing scores that are near the
threshold and up-weighting scores that are near either end of each
tool's scoring range. CAROL uses a different but also sophisticated
weighting system in combining the scores, with the same goal of
upweighting scores that are far from the threshold. In contrast, the
weighting in our WMV method relies on each tool's self-evaluation
of the classiﬁcation. Despite being comparatively very simplistic, the
resulting performance of the WMV is identical to that of Condel and
very similar to CAROL.
It must be noted, that an important consideration in benchmarks
such as the one conducted in this study, is the choice of the dataset.
Table 3
Classiﬁcation performance for a random set of 4985 variants annotated as disease-
associated in PhenCode.
Tool Sensitivity False negatives % Not predicted %
SIFT 0.74 0.22 0.05
PolyPhen2 0.88 0.12 0.00
MutPred 0.95 0.05 0.00
SNPs&GO 0.85 0.15 0.00
PANTHER 0.60 0.23 0.17
PhD-SNP 0.70 0.30 0.00
Mut. Assessor 0.64 0.19 0.17
Condel 0.81 0.19 0.00
CAROL 0.85 0.15 0.00
WMV 0.81 0.15 0.04
CoVEC (linear SVM) 0.91 0.09 0.00
Table 2
Evaluation results for the consensus methods. Prediction rate, sensitivity, speciﬁcity, correct rate and Matthews correlation coefﬁcient for different consensus strategies (abbrevi-
ations: PPH2 = PolyPhen2, PNTH = PANTHER, S&G = SNPs&GO, M/A = Mutation Assessor, PhD = PhD-SNP).
Tool Pred. Rate Sens. Spec. Correct Rate MCC
Condel 1.00 0.77 0.88 0.83 0.66
CAROL 0.99 0.79 0.85 0.82 0.64
WMV
(SIFT,PPH2)a 0.89 0.79 0.88 0.84 0.68
(SIFT,PPH2,M/A)b 0.96 0.79 0.88 0.84 0.67
(PPH2,S&G,PNTH,PhD + M/A) 0.97 0.75 0.93 0.84 0.69
(PPH2,S&G,PhD,M/A) 0.97 0.74 0.94 0.84 0.70
(PPH2,S&G,M/A) 0.96 0.80 0.92 0.86 0.73
(SIFT,PPH2,S&G,PNTH,PhD,M/A) 0.98 0.74 0.93 0.84 0.69
(SIFT,PPH2,S&G,M/A) 0.97 0.76 0.92 0.84 0.69
CoVEC
(Lin. kernel SVM) 1.00 0.83 0.90 0.87 0.74
(RBF kernel SVM) 1.00 0.84 0.89 0.87 0.74
a Similar to CAROL.
b Similar to Condel.
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The set must be adequately large, in order to have statistical power,
and must comprise of distinct and unambiguous cases. The propor-
tional composition of positive versus negative cases also inﬂuences
the reliability of the statistical metrics used to evaluate the perfor-
mance [35]. Accordingly, our evaluation was undertaken with equal
numbers of disease-causing mutations from HGMD (positive set)
and common variants from the 1000 Genomes Project Pilot project
(negative set). The composition of these datasets gives us conﬁdence
that the positive set consists of non-synonymous variants with strong
likelihood of functional effect. The choice of common variants for the
negative set is based on the hypothesis that the presence of an allele at
high frequency in each of genetically discrete populations may reﬂect
a scenario in which the variant is less likely to have a substantial func-
tional effect.
The nature and availability of the data, however, imposed a differ-
ent compromise on the benchmarking set. The pressure to collect a
large enough set has likely resulted in an overlap between our test
set and the training sets of some of the evaluated methods. Indeed,
the enhanced performance of MutPred (Table 1) could reﬂect the
use of HGMD as a training set in the development of this tool [3]
and thus a complete overlap with our positive set. Use of the
PhenCode-derived set of positive variants, however, which was se-
lected to exclude overlap with HGMD, showed that MutPred
maintained its high sensitivity. Interestingly, SNPs&GO and PhD-SNP
which used Uniprot data in their training showed a noticeable in-
crease in sensitivity with the PhenCode dataset, likely due to the
fact that a large section of PhenCode consists of the Uniprot data.
Overlap can be found in the negative set as well, as CAROL exploited
a similar approach to this study in drawing neutral variants out of
the 1000 Genomes Project data.
Previously, evaluations of functional variant prediction tools have
been presented [17,31], but they differ in their selection of methods
and testing data. Though some differences in the measured accuracy
values are expected, one would also expect that some trends should
be apparent across studies. Indeed there is complete agreement be-
tween our results and those of Thusberg et al. [31] for SNPs&GO and
PhD-SNP. The correct rate and MCC for PANTHER were also in agree-
ment, though our sensitivity and speciﬁcity differed signiﬁcantly. Our
metric values for SIFT, PolyPhen2 and MutPred were higher than
those reported by Thusberg et al., but were similar to those reported
by Gonzalez-Perez and Lopez-Bigas [17]. These observed differences
likely result from the source and composition of the test data. As
discussed in the above, overlap of test data with datasets used in
the individual development of these tools is clearly a concern, and
the different proportion of positive and negative sets may also play
a role in the differences observed between evaluation studies. We
attempted to control for these biases by ensuring the positive and
negative datasets were balanced and compliant with all of the tools'
requirements, resulting in comparable numbers of predicted variants
in both datasets across all tools. Random sampling factors may also
have had an effect on the performance, though our jackkniﬁng valida-
tion and cross-validation results (data not shown) suggest that this is
unlikely to be a major source of variability.
In conclusion, we evaluated the performance of seven indepen-
dently published methods that aim to predict the functional conse-
quences of alleles that result in amino acid substitutions, as well as
consensus approaches based on these methods. We conclude that,
out of the individual tools that we evaluated, MutPred offers the
best all around performance. PolyPhen2 provides the second best
sensitivity, after MutPred, for studies in which not missing potential
functional effects outweighs the cost of false positives. Both tools
offer a range of information on what the actual biochemical, structur-
al or functional effect of the substitution may be. SNPs&GO, on the
other hand, is the most applicable in situations where false positives
need to be minimized. We demonstrate that combining multiple pre-
diction tools provides a more even balance between sensitivity and
speciﬁcity than most of the individual methods, and that our
SVM-based consensus classiﬁer CoVEC is robust and well-suited to
the task of combining scores and can match or outperform existing
consensus solutions.
Awebsite implementing both CoVEC and theWMV classiﬁer is avail-
able at http://www.dcs.kcl.ac.uk/pg/frousiok/variants/index.html. Al-
ternatively, Perl scripts and modules aimed at assisting with the
preparation of data, the local execution of batch queries and the integra-
tion in local pipelines are also available from SourceForge: http://
sourceforge.net/projects/covec/ﬁles.
4. Materials and methods
4.1. Tool selection and execution
Seven individual tools and two consensus tools for predicting the
functional consequences of non-synonymous DNA sequence variation
were selected for comparison. All selected tools enable predictions of
both previously observed and novel variants and enable evaluation of
large numbers of variants through batch queries or scripted submis-
sion to their web-APIs.
The task of obtaining functional effect predictions from multiple
tools can be simpliﬁed with the use of meta-tools such as PON-P
[24] and the Ensembl SNP Effect Predictor [22], both of which serve
as gateways to a multitude of bioinformatics resources relevant to
the functional study of variants, including several of the selected
tools for this study (SIFT, PolyPhen2, SNPs&GO, PhD-SNP). However,
we opted to generate predictions for each tool individually, using
their dedicated interfaces. SIFT1 and PolyPhen22 were run as batch
queries on the respective web-servers. PhD-SNP, SNPs&GO andMuta-
tion Assessor were queried on-line by scripted submission of individ-
ual variants. MutPred was kindly executed locally by its authors. We
obtained PANTHER predictions indirectly via SNPs&GO. Condel and
CAROL were used through respective local installations.
4.2. Benchmarking data sets
In order to evaluate the prediction tools, we selected two sources
of human non-synonymous variant data; one that is enriched for var-
iants with conﬁrmed functional consequences and a second variant
dataset likely to contain a reduced level of functional variation.
The set of DNA variants with functional consequences comprise var-
iants previously implicated in the pathogenesis of inherited human dis-
ease and were extracted from HGMD Pro v.2011.1 [33]. The set of
putative neutral variation was selected from variants identiﬁed by the
1000 Genomes Project Pilot project [34] (released July 2010). The
pilot data is based on low coverage whole genome sequencing of 179
individuals, distributed in three groups with distinct geographic origin
(African, Caucasian, East-Asian). From the N15 million distinct SNPs
contained in the pilot data we selected non-synonymous variants
with a minor allele frequency greater or equal to 5% in each of the
three populations. This selection of variants should be enriched for var-
iants that do not have a functional consequence.
All variants were originally derived from the NCBI36/hg18 human
genome assembly and annotated with respect to the genes in which
they reside using Annovar [25]. Prior to being submitted for predic-
tion, they were converted to the NCBI37/hg19 assembly using the
UCSC Genome Browsers's liftOver utility3 [36] and cross-referenced
with the NCBI transcript RefSeq [37] and the Uniprot [32] databases
in order to obtain the amino acid sequence and protein identiﬁers.
After all processing, our putatively neutral data set from the 1000 Ge-
nomes Project comprised 7791 non-synonymous variants across
1 http://sift.jcvi.org/www/SIFT_chr_coords_submit.html
2 http://genetics.bwh.harvard.edu/pph2/bgi.shtml
3 http://genome.ucsc.edu/cgi-bin/hgLiftOver
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4555 genes — we deﬁne this set of variants as our negative set. In
order to size-match our neutral and functional cohorts, we randomly
selected a subset of the functionally enriched variants from the
HGMD catalog of disease-causing mutations with a maximum of 10
disease-causing variants per gene, resulting in 7779 variants across
1448 genes — we deﬁne this set of variants as our positive set.
As HGMD has been used to train some of the tools examined here,
an independent additional validation dataset was compiled. Single
amino acid substitution variants annotated in PhenCode [38] as
disease-associated were collected and compared to the HGMD Pro
catalog. After removing any potential overlap, a sample subset of
the remaining variants from PhenCode was randomly extracted,
consisting of 4985 amino acid substitutions in 1164 proteins.
4.3. Evaluation
The selected classiﬁcation tools were evaluated with metrics ap-
plicable for binary classiﬁcation problems [35]. We deﬁne the follow-
ing metrics: sensitivity — the proportion of the positive set classiﬁed
as having a functional consequence, speciﬁcity — the proportion of
the negative set not predicted to have a functional consequence, cor-
rect rate — the proportion of correctly classiﬁed cases from both
sets together. We also calculated the Matthews correlation coefﬁcient
(MCC) and area under the ROC curve (AUC).
These binary classiﬁcation metrics are limited in certain situations
within this study. Whilst SNPs&GO, PANTHER, PhD-SNP and Condel
offer a simple binary prediction, SIFT and PolyPhen2 generate three
ranked classes, Mutation Assessor generates ﬁve and MutPred none.
In order for the metrics to be applicable, the ranked classes were
merged down to simulate a binary classiﬁcation. Two scenarios
were considered: (i) The intermediate class was considered to be
neutral and (ii) it was considered to be damaging. In the case of Mu-
tation Assessor, which employs ﬁve classes, the two lowest probabil-
ity classes were binned together as neutral, the two highest
probability classes were merged as damaging, and the middle class
was considered under the two scenarios mentioned above. MutPred
does not explicitly classify the variants. Therefore we created three
ranked classes as follows: We considered all the variants which
scored below the threshold advised in the tool's documentation as
neutral. Variants scoring above the threshold, for which MutPred ad-
ditionally offered hypotheses about the nature of the mutation's ef-
fect, comprised our damaging class. Variants scoring above the
threshold, but lacking any hypothesis about the mutation's effect
were treated as the intermediate class, to be considered under the
two scenarios.
Direct comparison between these tools was further confounded,
as it is not uncommon for the tools to be unable to classify certain var-
iants. To address the issue of the number of submitted variants not
equaling the number of predictions, we recorded the prediction rate
(proportion of submitted cases for which a prediction was returned)
for each tool and calculated two versions of the accuracy metrics, one
based on the number of classiﬁed cases and one based on the number
of submitted cases (see Additional ﬁle 1).
To test the robustness of the performance metrics, we performed
10-fold jackkniﬁng, removing each time a different 10% of the vari-
ants, evenly from positive and negative cases and re-calculating the
correct rate each time. The values obtained from the 10 iterations
where consistent for each method (data not shown), with the highest
observed standard deviation b0.005.
4.4. Consensus classiﬁcation development
In order to evaluate the potential beneﬁt of incorporating outputs
frommultiple tools to improve predictions we implemented two con-
sensus approaches: a weighted majority vote score (WMV) and a sup-
port vector machine (SVM).
The WMV approach assigned a numerical value (Vi) to each of the
three deﬁned classes (damaging, intermediate and neutral) from each
of the selected tools. We assigned the value +2 for the damaging class,
+1 for the intermediate class, and −2 for the neutral class. A score of
0 was assigned when a method did not generate a prediction. The
weighted vote score was calculated by adding up the individual values
generated for each of the tools incorporated in the consensus model:
WMV ¼∑
i
V i : ð1Þ
Wedeﬁne 0 as the threshold value for theWVS. Negative values lead
to classiﬁcation of the variant as neutral and positive values as damag-
ing. If the votes add up to exactly 0 classiﬁcation is not possible.
The SVM-based consensus classiﬁer incorporates the raw output
scores generated by SIFT, PolyPhen2, SNPs&GO and Mutation Asses-
sor. We used SVMlight [39] to build the SVM model and perform
the classiﬁcation using either a linear kernel or a radial based function
(RBF) kernel with a g parameter of 0.0625 and the default C parame-
ter. A grid search for optimal C and g parameters for the RBF kernel
demonstrated a broad range of similarly well performing value com-
binations. To test the robustness of the predictor, we performed
10-fold cross-validation, by splitting our data into pairs of subsets
and using one subset of each pair to train the model and the other
to evaluate the accuracy. The training was performed in quadrupli-
cate, changing the number of variants used to train the model
(2000, 5000, 10000, 13000). The results were very consistent across
all 40 iterations (data not shown) with the standard deviation
b0.01, and accuracy improving less than 0.005 between the model
trained on 2000 variants and the model trained on 13000 variants.
Supplementary data to this article can be found online at http://
dx.doi.org/10.1016/j.ygeno.2013.06.005.
Acknowledgments
KF is funded by the Greek State Scholarships Foundation. The au-
thors also acknowledge support from the Department of Health via
the National Institute for Health Research (NIHR) comprehensive Bio-
medical Research Centre award to Guy's & St Thomas' NHS Founda-
tion Trust in partnership with King's College London and King's
College Hospital NHS Foundation Trust. The authors also thank Dr
Biao Li for kindly running MutPred on our behalf.
References
[1] P. Ng, S. Henikoff, SIFT: predicting amino acid changes that affect protein func-
tion, Nucleic Acids Res. 31 (2003) 3812.
[2] I. Adzhubei, S. Schmidt, L. Peshkin, et al., A method and server for predicting dam-
aging missense mutations, Nat. Methods 7 (2010) 248.
[3] B. Li, V. Krishnan, M. Mort, et al., Automated inference of molecular mechanisms
of disease from amino acid substitutions, Bioinformatics 25 (2009) 2744.
[4] R. Calabrese, E. Capriotti, P. Fariselli, et al., Functional annotations improve the
predictive score of human disease-related mutations in proteins, Hum. Mutat.
30 (2009) 1237.
[5] P. Thomas, A. Kejariwal, N. Guo, et al., Applications for protein sequence-function
evolution data: mRNA/protein expression analysis and coding SNP scoring tools,
Nucleic Acids Res. 34 (2006) W645.
[6] E. Capriotti, R. Calabrese, R. Casadio, Predicting the insurgence of human genetic
diseases associated to single point protein mutations with support vector ma-
chines and evolutionary information, Bioinformatics 22 (2006) 2729.
[7] B. Reva, Y. Antipin, C. Sander, Predicting the functional impact of protein muta-
tions: application to cancer genomics, Nucleic Acids Res. 39 (2011) e118.
[8] L. Bao, M. Zhou, Y. Cui, nsSNPAnalyzer: identifying disease-associated nonsynonymous
single nucleotide polymorphisms, Nucleic Acids Res. 33 (2005) W480.
[9] M. Lopes, C. Joyce, G. Ritchie, et al., A combined functional annotation score for
non-synonymous variants, Hum. Hered. 73 (2012) 47.
[10] M. Barenboim, M. Masso, I. Vaisman, D. Jamison, Statistical geometry based pre-
diction of nonsynonymous SNP functional effects using random forest and
neuro-fuzzy classiﬁers, Proteins Struct. Funct. Genet. 71 (2008) 1930.
[11] Y. Bromberg, B. Rost, SNAP: predict effect of non-synonymous polymorphisms
and function, Nucleic Acids Res. 35 (2007) 3823.
[12] E. Capriotti, R. Altman, Improving the prediction of disease-related variants using
protein three-dimensional structure, BMC Bioinforma. 12 (2011) S3.
227K. Frousios et al. / Genomics 102 (2013) 223–228
[13] C. Chelala, A. Khan, N. Lemoine, SNPnexus: a web database for functional annota-
tion of newly discovered and public domain single nucleotide polymorphisms,
Bioinformatics 25 (2008) 655.
[14] L. Conde, J. Vaquerizas, H. Dopazo, et al., PupaSuite: ﬁnding functional single nu-
cleotide polymorphisms for large-scale genotyping purposes, Nucleic Acids Res.
34 (2006) W621.
[15] J. Dantzer, C. Moad, R. Heiland, S. Mooney, MutDB services: interactive structural
analysis of mutation data, Nucleic Acids Res. 33 (2005) W311.
[16] C. Ferrer-Costa, J. Gelpi, L. Zamakola, et al., PMUT: a web-based tool for the anno-
tation of pathological mutations of proteins, Bioinformatics 21 (2005) 3176.
[17] A. Gonzalez-Perez, N. Lopez-Bigas, Improving the assessment of the outcome of
nonsynonymous SNVs with a consensus deleteriousness score, Condel, Am. J.
Hum. Genet. 88 (2011) 440.
[18] B. Hemminger, B. Saelim, F. Sullivan, TAMAL: an integrated approach to choosing
SNPs for genetic studies of human complex traits, Bioinformatics 22 (2006) 626.
[19] H. Kang, K. Choi, B. Kim, et al., FESD: a functional element SNPs database in
human, Nucleic Acids Res. 33 (2005) D518.
[20] R. Karchin, M. Diekhans, L. Kelly, et al., LS-SNP: large-scale annotation of coding
non-synonymous SNPs based on multiple information sources, Bioinformatics
21 (2005) 2814.
[21] P. Lee, H. Shatkay, F-SNP: computationally predicted functional SNPs for disease
association studies, Nucleic Acids Res. 36 (2008) D820.
[22] W. McLaren, B. Pritchard, D. Rios, et al., Deriving the consequences of genomic vari-
ants with the Ensembl API and SNP Effect Predictor, Bioinformatics 26 (2010) 2069.
[23] J. Reumers, S. Maurer-Stroh, J. Schymkowitz, F. Rousseau, SNPeffect v2.0: a new step
in investigating the molecular phenotypic effects of human non-synonymous SNPs,
Bioinformatics 22 (2006) 2183.
[24] J. Thusberg, M. Vihinen, Pathogenic or not? And if so, then how? Studying the ef-
fects of missense mutations using bioinformatics methods, Hum. Mutat. 30
(2009) 703.
[25] K. Wang, M. Li, H. Hakonarson, ANNOVAR: functional annotation of genetic vari-
ants from high-throughput sequencing data, Nucleic Acids Res. 38 (2010) e164.
[26] H. Yuan, J. Chiou, W. Tseng, et al., FASTSNP: an always up-to-date and extendable
service for SNP function analysis and prioritization, Nucleic Acids Res. 34 (2006)
W635.
[27] P. Yue, E. Melamud, J. Moult, SNPs3D: candidate gene and SNP selection for asso-
ciation studies, BMC Bioinforma. 7 (2006) 166.
[28] R. Karchin, Next generation tools for the annotation of human SNPs, Brief.
Bioinform. 10 (2008) 35.
[29] S. Coassin, A. Brandstätter, F. Kronenberg, Lost in the space of bioinformatics
tools: a constantly updated survival guide for genetic epidemiology. The GenEpi
Toolbox, Atherosclerosis 209 (2010) 321.
[30] M. Cline, R. Karchin, Using bioinformatics to predict the functional impact of
SNVs, Bioinformatics 27 (2011) 441.
[31] J. Thusberg, A. Olatubosun, M. Vihinen, Performance of mutation pathogenicity
prediction methods on missense variants, Hum. Mutat. 32 (2011) 1.
[32] The UniProt Consortium, Ongoing and future developments at the Universal Pro-
tein Resource, Nucleic Acids Res. 39 (2011) D214.
[33] P. Stenson, M. Mort, E. Ball, et al., The human gene mutation database: 2008 up-
date, Genome Med. 1 (2009) 13.
[34] The 1000 Genomes Project Consortium, A map of human genome variation from
population-scale sequencing, Nature 467 (2010) 1061.
[35] P. Baldi, S. Brunak, Y. Chauvin, et al., Assessing the accuracy of prediction algo-
rithms for classiﬁcation: an overview, Bioinformatics 16 (2000) 412.
[36] P. Fujita, B. Rhead, A. Zweig, et al., The UCSC Genome Browser database: update
2011, Nucleic Acids Res. 39 (2011) D876.
[37] K. Pruitt, T. Tatusova, D. Maglott, NCBI reference sequence (RefSeq): a curated
non-redundant sequence database of genomes, transcripts and proteins, Nucleic
Acids Res. 33 (2005) D501.
[38] B. Giardine, C. Riemer, T. Hefferon, et al., PhenCode: connecting ENCODE data
with mutations and phenotype, Hum. Mutat. 28 (2007) 554.
[39] T. Joachims, Making large-scale SVM learning practical, in: B. Schoelkopf, C.
Burges, A. Smola (Eds.), Advances in Kernel Methods — Support Vector Learning,
MIT-Press, 1999.
228 K. Frousios et al. / Genomics 102 (2013) 223–228
